EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca, EMA (published 12th January 2021)

The assessment will proceed under an accelerated timeline, and an opinion on the marketing authorisation for use in the EU could be issued by 29 January.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news